1,801 research outputs found

    Genetic Improvement of Software: a Comprehensive Survey

    Get PDF
    Genetic improvement (GI) uses automated search to find improved versions of existing software. We present a comprehensive survey of this nascent field of research with a focus on the core papers in the area published between 1995 and 2015. We identified core publications including empirical studies, 96% of which use evolutionary algorithms (genetic programming in particular). Although we can trace the foundations of GI back to the origins of computer science itself, our analysis reveals a significant upsurge in activity since 2012. GI has resulted in dramatic performance improvements for a diverse set of properties such as execution time, energy and memory consumption, as well as results for fixing and extending existing system functionality. Moreover, we present examples of research work that lies on the boundary between GI and other areas, such as program transformation, approximate computing, and software repair, with the intention of encouraging further exchange of ideas between researchers in these fields

    Assessment of the ergogenic effect of caffeine supplementation on mood, anticipation timing, and muscular strength in older adults

    Get PDF
    The effect of caffeine to promote improvements in mood, cognition, and exercise performance has been well established in young and athletic adults. However, little is known about whether such nutritional ergogenic aids are effective in enhancing psychological well-being, physiological or cognitive performance in older adults. This study assesses the ergogenic effect of caffeine on mood, perceptual-motor coupling, and muscular strength in an older human population. Following a familiarization session, 12 apparently healthy volunteers (nine females and three males; 69 ± 6 years) completed two laboratory visits. "Pre ingestion" trials of mood state Brunel Mood State Inventory (BRUMS) and coincidence anticipation performance (Bassin anticipation timer) at slow (3 mph) and fast (8 mph) stimulus speeds were completed on both visits. Using a randomized, double-blind, cross-over design, participants consumed either caffeine (3 mg/kg body mass) or a placebo. Sixty minutes postingestion participants repeated the trials before completing a set of 10 consecutive repetitions of maximal knee extension using isokinetic dynamometry. Rating of perceived exertion (RPE) was assessed following the fifth and final repetition. Caffeine ingestion significantly improved mood state scores for vigor by 17% (P = 0.009) and reduced absolute error by 35% (P = 0.045) during coincidence anticipation assessment at 8 mph compared to placebo. There were no other significant effects. Caffeine ingestion failed to augment maximal voluntary contraction of the knee extensors and RPE did not prove to be significantly different to from placebo (P > 0.33 in each case). Acute caffeine ingestion may not be an effective ergogenic aid for improving muscular strength in older adults but could possibly be used as a nutrition supplement for enhancing mood and improving cognitive performance in daily living tasks where interceptive timing skills are required

    Environmental controls on daytime net community calcification on a Red Sea reef flat

    Get PDF
    Coral growth and carbonate accumulation form the foundation of the coral reef ecosystem. Changes in environmental conditions due to coastal development, climate change, and ocean acidification may pose a threat to net carbonate production in the near future. Controlled laboratory studies demonstrate that calcification by corals and coralline algae is sensitive to changes in aragonite saturation state (Ωa), as well as temperature, light, and nutrition. Studies also show that the dissolution rate of carbonate substrates is impacted by changes in carbonate chemistry. The sensitivity of coral reefs to these parameters must be confirmed and quantified in the natural environment in order to predict how coral reefs will respond to local and global changes, particularly ocean acidification. We estimated the daytime hourly net community metabolic rates, both net community calcification (NCC) and net community productivity (NCP), at Sheltered Reef, an offshore platform reef in the central Red Sea. Average NCC was 8 ± 3 mmol m[superscript −2] h[superscript −1] in December 2010 and 11 ± 1 mmol m[superscript −2] h[superscript −1] in May 2011, and NCP was 21 ± 7 mmol m[superscript −2] h[superscript −1] in December 2010 and 44 ± 4 mmol m[superscript −2] h[superscript −1] in May 2011. We also monitored a suite of physical and chemical properties to help relate the rates at Sheltered Reef to published rates from other sites. While previous research shows that short-term field studies investigating the NCC–Ωa relationship have differing results due to confounding factors, it is important to continue estimating NCC in different places, seasons, and years, in order to monitor changes in NCC versus Ω in space and time, and to ultimately resolve a broader understanding of this relationship.National Science Foundation (U.S.) (Graduate Research Fellowship

    N-methylformamide: antitumour activity and metabolism in mice.

    Get PDF
    The antitumour activities of N-methylformamide, N-ethylformamide and formamide against a number of murine tumours in vivo (Sarcoma 180, M5076 ovarian sarcoma and TLX5 lymphoma) have been estimated. In all cases N-methyl-formamide had significant activity, formamide had marginal or no activity and N-ethylformamide had no significant activity. N-methylformamide and N-ethylformamide were equitoxic to the TLX5 lymphoma in vitro. Formamide was found as a metabolite in the plasma and urine of animals given N-methylformamide and N-ethylformamide, but excretion profiles do not support the hypothesis that formamide is an active antitumour species formed from N-alkylformamides. No appreciable metabolism of N-methylformamide occurred under a variety of conditions with liver preparations in vitro. N-methylformamide, but not N-ethylformamide or formamide, reduced liver soluble non-protein thiols by 59.8% 1 h after administration of an effective antitumour dose

    BRCA1 5382insC mutation in sporadic and familial breast and ovarian carcinoma in Scotland.

    Get PDF
    A restriction site-generating polymerase chain reaction (RG-PCR) assay was developed to detect the BRCA1 5382insC mutation that has been reported in multiple, apparently unrelated breast/ovarian carcinoma families. The assay has been used to screen tumour DNA from 250 breast cancer patients (aged 19-86 years) and from 80 ovarian cancer patients (aged 25-90 years) in a local population of patients with no known family history. Altogether, 0/80 (0%) ovarian and 1/250 (0.4%) breast tumour DNAs were found to have the 5382insC mutation. The sole positive case was a 26-year-old woman (BC185) with no known family history. One of the reasons for carrying out this analysis was that the 5382insC mutation had previously been shown to segregate with the disease in a very large Scottish 'West Lothian' kindred having breast/ovarian carcinoma. To investigate whether this apparently isolated case and the known family might be related, haplotypes for the markers D17S855, D17S1322, D17S1323 and D17S1327 were analysed. The mutant haplotype in the large kindred was identical to that reported in all other 5382insC mutation families for all markers with the exception of D17S1327. This implies that there has been a recombination event at the telomeric end of common ancestral haplotype in this family. Since the isolated case we identified carries the 'complete' common haplotype, it is unlikely that she is closely related to the West Lothian family

    Spherical equivalence of cylindrical explosives: Effect of charge shape on deflection of blast-loaded plates

    Get PDF
    Quantification of near-field blast loading is a pressing issue for defence, transport security, and structural engineering. Realistic explosion scenarios often involve the detonation of non-spherical high explosive charges, rather than the idealised spherical/hemispherical explosives assumed in commonly employed semi-empirical approaches. Additionally, near-field effects are of great importance when assessing structural damage and injury risk from such an event. There is a need, therefore, to incorporate the effects of charge shape and the resulting loading distribution in simplified engineering-level tools using adjustments based on sound physical principles. This article details the development of an energy equivalent formulation to derive spherical equivalence factors, with the methodology illustrated for the scenario of a centrally detonated cylindrical explosive charge. A validated two-part numerical model is used to generate specific impulse distributions and quantify the resulting plate deformation , for a wide range of cylindrical aspect ratios (0.20 ≤ L/D ≤ 5), at a range of near-field scaled distances (0.108 ≤ Z ≤ 0.485 m/kg 1/3) for different sized structural targets. A series of verification examples are used to demonstrate the accuracy of the method, with the peak deflection under the equivalent spherical charge matching peak deflection under the cylindrical charge to within ∼4%. The method developed in this article could be extended to find equivalence between any two systems with complex distributed loading, allowing for a fast running engineering approximation in cases where detailed modelling is inappropriate or infeasible

    Analysis of clinical outcomes according to original treatment groups 16 years after the pivotal IFNB-1b trial

    Get PDF
    BACKGROUND: Evidence for efficacy of disease-modifying drugs in multiple sclerosis (MS) comes from trials of short duration. We report results from a 16 y, retrospective follow-up of the pivotal interferon beta-1b (IFNB-1b) study. METHODS: The 372 trial patients were randomly assigned to placebo (n=123), IFNB-1b 50 microg (n=125) or IFNB-1b 250 microg (n=124) subcutaneously every other day for at least 2 y. Some remained randomised for up to 5 y but, subsequently, patients received treatment according to physicians' discretion. Patients were re-contacted and asked to participate. Efficacy related measures included MRI parameters, relapse rate, the Expanded Disability Status Scale, the Multiple Sclerosis Functional Composite Measure and conversion to secondary progressive MS. RESULTS: Of the 88.2% (328/372) of patients who were identified, 69.9% (260/372) had available case report forms. No differences in outcome between original randomisation groups could be discerned using standard disability and MRI measures. However, mortality rates among patients originally treated with IFNB-1b were lower than in the original placebo group (18.3% (20/109) for placebo versus 8.3% (9/108) for IFNB-1b 50 microg and 5.4% (6/111) for IFNB-1b 250 microg). CONCLUSIONS: The original treatment assignment could not be shown to influence standard assessments of long-term efficacy. On-study behaviour of patients was influenced by factors that could not be controlled with the sacrifice of randomisation and blinding. Mortality was higher in patients originally assigned to placebo than those who had received IFNB-1b 50 microg or 250 microg. The dataset provides important resources to explore early predictors of long-term outcome
    • …
    corecore